BMND — Biomind Labs Cashflow Statement
0.000.00%
Last trade - 00:00- CA$27.54m
- CA$28.71m
Annual cashflow statement for Biomind Labs, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4.33 | -2.99 | -1.19 | -0.26 | -0.85 |
| Depreciation | |||||
| Non-Cash Items | 2.29 | 0.604 | 0.182 | -0.15 | 0.459 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.104 | 0.186 | 0.229 | 0.047 | 0.322 |
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -2.12 | -2.15 | -0.766 | -0.354 | -0.068 |
| Capital Expenditures | -0.045 | 0 | — | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | 0 | — | — | — |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.044 | 0 | — | — | — |
| Financing Cash Flow Items | — | — | — | -0.005 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 4.47 | -0.039 | 0.762 | 0.302 | 0.086 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2.27 | -2.25 | -0.002 | -0.024 | -0 |